Schedule 13G ownership disclosure
VIRIOS THERAPEUTICS INC
Security class unavailable · CUSIP: 92829J104
Event date: 2023-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,149,749
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-23-001606
- Form type
- SC 13G
- Filer
- Corday Brian David
- CIK
- CIK 1322787
- Filed
- Feb 13, 2023
- Reporting period
- Feb 13, 2023
- Description
- Schedule 13G beneficial ownership